News & Updates
Filter by Specialty:

SGLT2i cuts cardiovascular, renal risk in diabetics
Compared with dipeptidyl peptidase-4 inhibitors (DPP4i), the use of sodium glucose co-transporter 2 inhibitors (SGLT2i) is associated with lower risk of cardiovascular disease, renal events, and heart failure (HF) hospitalization among patients with diabetes, reports a recent study.
SGLT2i cuts cardiovascular, renal risk in diabetics
22 Oct 2022
Hysterectomy tied to increased diabetes risk
Undergoing a hysterectomy, particularly at a young age, may be associated with an increased risk of developing diabetes, according to a study from France presented at EASD 2022.
Hysterectomy tied to increased diabetes risk
21 Oct 2022
Long-term tapinarof use proven safe, effective in plaque psoriasis
Continuous and intermittent use of tapinarof cream 1% once daily (QD) for up to 1 year is effective in patients with mild-to-severe plaque psoriasis, without serious safety concerns, according to a study. In addition, it has shown durable efficacy and a remittive effect of at least 4 months off therapy.
Long-term tapinarof use proven safe, effective in plaque psoriasis
21 Oct 2022
Peanut intake may help with weight loss
In the context of an energy-restricted diet, a weight-loss diet involving daily consumption of 70 g of lightly salted dry-roasted peanuts yielded similar weight loss results as a traditional low-fat weight-loss diet after 6 months in adults at high risk for type 2 diabetes (T2D), a study has shown.